Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease

Documenti analoghi

• Subcutaneous Foslevodopa as Novel Rescue Therapy for Akinetic Crisis in Parkinson's Disease: A Case Report
  di: Bendix Labeit, et al.
  Pubblicazione: (2025)
• Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS ‐Park Cohort
  di: Clément Desjardins, et al.
  Pubblicazione: (2025)
• “Alternating” the Diagnosis after 40 Years of Disease: The Thousand Faces of ATP1A3 Mutation
  di: Silvia Gallo, et al.
  Pubblicazione: (2024)
• Peripheral Neuropathy during Subcutaneous Foslevodopa/Foscarbidopa Infusion in Parkinson's Disease: A Case Series
  di: Lucie Vial‐Daragon, et al.
  Pubblicazione: (2026)
• Continuous Subcutaneous Foslevodopa‐Foscarbidopa in Parkinson's Disease: A Mini‐Review of Current Scope and Future Outlook
  di: Mickael Aubignat, et al.
  Pubblicazione: (2024)